Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Willebrand factor A domain-containing protein 5B1 (VWA5B1) is a member of the von Willebrand factor A (VWA) domain-containing protein family. It is a protein-coding gene with currently poorly defined biological functions in human physiology or pathology. The protein is predicted to be extracellular, and its gene is associated with certain inherited diseases (including Usher syndrome type If and Niemann–Pick disease type C2), but there is no direct evidence for its causal involvement, nor is it established as a classical therapeutic target, receptor, enzyme, transporter, or transcription factor[5][3]. No drugs are known to modulate VWA5B1, and major databases do not currently list it as a receptor or validated target for therapeutic intervention. Its role may be structural or involved in extracellular protein-protein interactions, but this remains speculative[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand factor A domain-containing protein 5B1 (VWA5B1).